Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1991
Characterization of the renal effects and renal elimination of sulotroban in the dogW A Mann, G E Welzel, R S Goldstein, et al.British Journal of Pharmacology|July 1, 1988
Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkeyD P Brooks, P F Koster, F L Stassen, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta)L B Kinter, I McConnell, B T Goodwin, et al.European Journal of Pharmacology|January 24, 1989
Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirementsD P Brooks, P F Koster, C R Albrightson, et al.Journal of Medicinal Chemistry|July 1, 1987
Synthesis and evaluation of non-catechol D-1 and D-2 dopamine receptor agonists: benzimidazol-2-one, benzoxazol-2-one, and the highly potent benzothiazol-2-one 7-ethylaminesJ Weinstock, D E Gaitanopoulos, O D Stringer, et al.Journal of Medicinal Chemistry|June 1, 1986
Potent vasopressin antagonists lacking the proline residue at position 7F E Ali, W Bryan, H L Chang, et al.Journal of Medicinal Chemistry|December 1, 1987
Potent vasopressin antagonists modified at the carboxy-terminal tripeptide tailF E Ali, H L Chang, W F Huffman, et al.Journal of Medicinal Chemistry|April 1, 1989
A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activityW F Huffman, C Albrightson-Winslow, B Brickson, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
Vasopressin antidiuretic agonist and antagonist activity in dogs: structural and stereochemical relationship between bridge and carboxyl terminusC R Albrightson-Winslow, B Brickson, D P Brooks, et al.Journal of Medicinal Chemistry|February 1, 1989
Structure-activity relationships of novel vasopressin antagonists containing C-terminal diaminoalkanes and (aminoalkyl)guanidinesJ F Callahan, D Ashton-Shue, H G Bryan, et al.Pageof 6